No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Rebecca LajaunieLise CuzinRomain PalichAlain MakinsonFirouzé Bani-SadrClaudine DuvivierCedric ArvieuxDavid ReyIsabelle Poizot-MartinCyril DelpierrePierre DelobelGuillaume Martin-Blondelnull nullPublished in: HIV medicine (2021)
In this large cohort of PLHIV with a history of KS and ART-controlled HIV replication, KS relapses were described in 3.2% of the patients, and were not more frequent when a PI-containing ART regimen has been switched to a PI-free regimen. Our results do not support a specific effect of PI on KS.